Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T. Gotta V, et al. Among authors: buclin t. Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19. doi: 10.1007/s00280-014-2599-1. Epub 2014 Oct 9. Cancer Chemother Pharmacol. 2014. PMID: 25297989 Free article. Clinical Trial.
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.
Widmer N, Decosterd LA, Csajka C, Leyvraz S, Duchosal MA, Rosselet A, Rochat B, Eap CB, Henry H, Biollaz J, Buclin T. Widmer N, et al. Among authors: buclin t. Br J Clin Pharmacol. 2006 Jul;62(1):97-112. doi: 10.1111/j.1365-2125.2006.02719.x. Br J Clin Pharmacol. 2006. PMID: 16842382 Free PMC article.
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Marzolini C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T, Biollaz J, Lejeune F. Marzolini C, et al. Among authors: buclin t. Cancer Chemother Pharmacol. 1998;42(6):433-40. doi: 10.1007/s002800050842. Cancer Chemother Pharmacol. 1998. PMID: 9788568 Clinical Trial.
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.
Widmer N, Béguin A, Rochat B, Buclin T, Kovacsovics T, Duchosal MA, Leyvraz S, Rosselet A, Biollaz J, Decosterd LA. Widmer N, et al. Among authors: buclin t. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 25;803(2):285-92. doi: 10.1016/j.jchromb.2004.01.006. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15063337
Imatinib plasma levels: correlation with clinical benefit in GIST patients.
Widmer N, Decosterd LA, Csajka C, Montemurro M, Haouala A, Leyvraz S, Buclin T. Widmer N, et al. Among authors: buclin t. Br J Cancer. 2010 Mar 30;102(7):1198-9. doi: 10.1038/sj.bjc.6605584. Epub 2010 Feb 23. Br J Cancer. 2010. PMID: 20179709 Free PMC article. No abstract available.
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
Arab-Alameddine M, Lubomirov R, Fayet-Mello A, Aouri M, Rotger M, Buclin T, Widmer N, Gatri M, Ledergerber B, Rentsch K, Cavassini M, Panchaud A, Guidi M, Telenti A, Décosterd LA, Csajka C; Swiss HIV Cohort Study. Arab-Alameddine M, et al. Among authors: buclin t. J Antimicrob Chemother. 2014 Sep;69(9):2489-98. doi: 10.1093/jac/dku131. Epub 2014 May 12. J Antimicrob Chemother. 2014. PMID: 24821595 Free article.
336 results